Gene · 1373
Papers2,057
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,057
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative multi-omics deciphers the spatial characteristics of host-gut microbiota interactions in Crohn's disease. | Cell Rep Med | 2023 | 37172588 | PubTator, text mining | PubMed |
| Perspectives of Rare Disease Experts on Newborn Genome Sequencing. | JAMA Netw Open | 2023 | 37155167 | PubTator, text mining | PubMed |
| Intrinsic sexual dimorphism in the placenta determines the differential response to benzene exposure. | iScience | 2023 | 37153445 | PubTator, text mining | PubMed |
| The remarkable journey of one female individual with ornithine transcarbamylase deficiency diagnosed post-mortem. | JIMD Rep | 2023 | 37151362 | PubTator, text mining | PubMed |
| The impact of epigenetic landscape on ovarian cells in infertile older women undergoing IVF procedures. | Clin Epigenetics | 2023 | 37143127 | PubTator, text mining | PubMed |
| Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma. | Clin Epigenetics | 2023 | 37120619 | PubTator, text mining | PubMed |
| Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence. | Metabolites | 2023 | 37110218 | PubTator, text mining | PubMed |
| Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses. | Int J Mol Sci | 2023 | 37108625 | PubTator, text mining | PubMed |
| Specific Deoxyceramide Species Correlate with Expression of Macular Telangiectasia Type 2 (MacTel2) in a SPTLC2 Carrier HSAN1 Family. | Genes (Basel) | 2023 | 37107689 | PubTator, text mining | PubMed |
| A novel Alzheimer's disease prognostic signature: identification and analysis of glutamine metabolism genes in immunogenicity and immunotherapy efficacy. | Sci Rep | 2023 | 37106067 | PubTator, text mining | PubMed |
| Extending inherited metabolic disorder diagnostics with biomarker interaction visualizations. | Orphanet J Rare Dis | 2023 | 37101200 | PubTator, text mining | PubMed |
| Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance. | Cell Mol Biol Lett | 2023 | 37085753 | PubTator, text mining | PubMed |
| The Role of Carbamoyl Phosphate Synthetase 1 as a Prognostic Biomarker in Patients With Acetaminophen-induced Acute Liver Failure. | Clin Gastroenterol Hepatol | 2023 | 37054752 | PubTator, text mining | PubMed |
| NAGS, CPS1, and SLC25A13 (Citrin) at the Crossroads of Arginine and Pyrimidines Metabolism in Tumor Cells. | Int J Mol Sci | 2023 | 37047726 | PubTator, text mining | PubMed |
| ABL kinases regulate the stabilization of HIF-1α and MYC through CPSF1. | Proc Natl Acad Sci U S A | 2023 | 37040401 | PubTator, text mining | PubMed |
| Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancers. | Front Oncol | 2023 | 37035141 | PubTator, text mining | PubMed |
| A novel zinc metabolism-related gene signature to predict prognosis and immunotherapy response in lung adenocarcinoma. | Front Immunol | 2023 | 37033934 | PubTator, text mining | PubMed |
| Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer. | Nat Genet | 2023 | 37024582 | PubTator, text mining | PubMed |
| A novel integrative multi-omics approach to unravel the genetic determinants of rare diseases with application in sinusoidal obstruction syndrome. | PLoS One | 2023 | 37018234 | PubTator, text mining | PubMed |
| Genomic comparison of two Streptococcus suis serotype 1 strains recovered from porcine and human disease cases. | Sci Rep | 2023 | 37009816 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1373/papers?page=14